LeonaBio, Inc.(LONA)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Limited institutional coverage
Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 44 institutional filers currently hold this stock.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
LONA Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for LeonaBio, Inc. (LONA), a Healthcare sector company. LONA is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 44 institutional filers currently hold this stock. Top institutional holders of LONA by reported 13-F value include PERCEPTIVE ADVISORS, ADAR1 Capital Management, ACORN CAPITAL ADVISORS, based on the most recent SEC filings. LONA trades on the Nasdaq exchange and files with the SEC under CIK 1620463. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LONA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for LeonaBio, Inc. directly from SEC EDGAR.
Net Income
Q2 2026
$-19.0M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
-8.9% YoYOperating Income
-1.4% YoYEPS (Diluted)
+1.9% YoYTotal Assets
+56.8% YoYOp. Cash Flow
+52.9% YoYFree Cash Flow
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Net Income | $-105.6M -8.9% | $-96.9M +17.6% | $-117.7M -23.0% | $-95.6M -74.4% | $-54.9M -174.9% | $-20.0M |
| Operating Income | $-102.3M -1.4% | $-100.9M +19.6% | $-125.5M -20.6% | $-104.0M -62.5% | $-64.0M -220.2% | $-20.0M |
| EPS (Diluted) | $-24.70 +1.9% | $-25.19 -715.2% | $-3.09 -22.1% | $-2.53 -69.8% | $-1.49 | — |
| Total Assets | $92.2M +56.8% | $58.8M -63.3% | $160.2M -37.9% | $258.2M -22.2% | $332.0M +18.8% | $279.6M |
| Operating Cash Flow | $-45.7M +52.9% | $-97.2M +3.6% | $-100.8M -39.0% | $-72.5M -68.1% | $-43.1M -78.7% | $-24.1M |
| Free Cash Flow | — | $-97.2M +3.8% | $-101.1M -37.3% | $-73.6M -64.8% | $-44.7M -69.0% | $-26.4M |
Get alerted when LONA's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for LeonaBio, Inc. including:
Top Institutional Holders of LONA
PERCEPTIVE ADVISORS LLC
$17.1M1,859,322 shADAR1 Capital Management, LLC
$7.1M777,100 shACORN CAPITAL ADVISORS, LLC
$5.8M634,539 shCommodore Capital LP
$4.3M464,398 shTCG Crossover Management, LLC
$4.3M464,398 shNEA Management Company, LLC
$4.3M464,398 shKalehua Capital Management LLC
$3.6M393,701 shSpruce Street Capital LP
$3.6M393,701 shBlackstone Inc.
$3.0M324,638 shADAGE CAPITAL PARTNERS GP, L.L.C.
$2.8M300,000 sh
| Fund | Value | Shares |
|---|---|---|
| PERCEPTIVE ADVISORS LLC | $17.1M | 1,859,322 |
| ADAR1 Capital Management, LLC | $7.1M | 777,100 |
| ACORN CAPITAL ADVISORS, LLC | $5.8M | 634,539 |
| Commodore Capital LP | $4.3M | 464,398 |
| TCG Crossover Management, LLC | $4.3M | 464,398 |
| NEA Management Company, LLC | $4.3M | 464,398 |
| Kalehua Capital Management LLC | $3.6M | 393,701 |
| Spruce Street Capital LP | $3.6M | 393,701 |
| Blackstone Inc. | $3.0M | 324,638 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $2.8M | 300,000 |
More Healthcare Companies
View all Healthcare →Put LONA on your watchlist
Track score changes the day LeonaBio, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is LONA a good stock to buy?
13F Pro's AI-powered analysis of LeonaBio, Inc. (LONA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for LONA are available on the LONA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. LONA is classified as a small company.
Which hedge funds own LONA?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling LONA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of LeonaBio, Inc.'s investment landscape.